购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-21(compound 17)是一种针对hydroxysteroid 17?-dehydrogenase 13 (HSD17B13)的高效抑制剂,其IC50对雌二醇和白三烯B3分别为小于0.1 μM和小于1 μM。该化合物在非酒精性脂肪肝疾病(NAFLD)包括NASH(非酒精性脂肪性肝炎)的研究中展现出重要价值。
HSD17B13-IN-21(compound 17)是一种针对hydroxysteroid 17?-dehydrogenase 13 (HSD17B13)的高效抑制剂,其IC50对雌二醇和白三烯B3分别为小于0.1 μM和小于1 μM。该化合物在非酒精性脂肪肝疾病(NAFLD)包括NASH(非酒精性脂肪性肝炎)的研究中展现出重要价值。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-21 (compound 17) serves as a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC50 of < 0.1 μM for estradiol and < 1 μM for Leukotriene B3 as substrates. This compound plays a crucial role in the management of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH) [1]. |
分子量 | 465.35 |
分子式 | C21H18Cl2N2O4S |
CAS No. | 2758802-18-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.